Bristol Myers Squibb Investor
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Invests into
.jpeg)
Technology:
Biotechnology, Cell_Therapies, Health Care, Medical, Pharmaceutical
Industry:
AI, End-to-end Drug Development
Headquarters:
New York, New York, United States
Founded Date:
1887-01-01
Employees Number:
10001+
Funding Status:
IPO
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture, Venture
Number Of Exits:
10
Acquisitions Number:
Made Acquisitions
Investors Number:
13
Total Funding:
80000000
Estimated Revenue:
$1B to $10B
Last Funding Date:
2022-02-15
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership